Session 1192: Familial and Hereditary Cancer
Cochair(s): P Hainaut, WC Hahn
Date: Mon 11 February 2002,
Time: 11:30 - 13:00
Location: Amphithéâtre Duclaux
Oral Presentations
Time |
Number |
Title / Authors / Affiliations |
11:30 |
219 |
Maternal
mosaicism for a second mutational event, a novel
deletion, might induce a more severe clinical
manifestations in the siblings of a familial adenomatous
polyposis family harboring a new germ-line mutation in
exon 9, due to the alternative splicing mechanism in the
APC gene.
D Amikam, S Davidson, L Leshanski, G Rennert, S
Eidelman
1Molecular
Oncology Laboratory, 3Gastroenterology
Institute; Rambam Medical Center, Haifa, Israel,
2Department of Community Medicine and
Epidemiology, Carmel Medical Center, Haifa, Israel,
4Department of Biotechnology in Medicine,
Tel-Hai Academic College, Tel-Hai, Israel |
11:45 |
220 |
Sporadic
hemangioblastoma of the CNS and von Hippel-Lindau
diseases-updated results
M Smrcka, O Novotny, V Smrcka, R Gaillyova, E
Krepelova
1Masaryk
University Brno Medical School, University Hospital Brno,
Czech Republic, Czech Republic, 2Depatment of
Medical Genetics, University Hospital Brno, Czech
Republic, Czech Republic, 3Department of
Medical Genetics, University General Hospital, Prague,
Czech Republic |
12:00 |
221 |
Molecular genetic
testing for Neurofibromatosis type 1
(NF1).
LM Messiaen, T Callens, N Goderis, G Mortier, F Speleman,
A De Paepe
Dpt. Medical Genetics,
Ghent University Hospital, Belgium |
12:15 |
222 |
Spontaneously
immortalised T cell lines from Nijmegen Breakage Syndrome
(NBS) patients demonstrate abnormal G1/S arrest and gains
of 2p and 8q
JK Siwicki, S Degerman, M Berglund, C Larsson, J Rygier,
K Chrzanowska, G Roos
1Department
of Immunology, Maria Sklodowska Memorial Cancer Center
and Institute of Oncology, Poland, Sweden,
2Department of Medical Biosciences, Pathology,
Umea University, Umea, Sweden, 3Department of
Molecular Medicine, Karolinska Hospital, Sweden, Warsaw,
4Cytogenetic Laboratory, Maria Sklodowska
Memorial Cancer Center and Institute of Oncology, Poland,
Warsaw, 5Department of Medical Genetics,
Children Memorial Health Institute, Warsaw,
Poland |
12:30 |
223 |
The Transforming
Growth Factor-alpha/Epidermal Growth Factor Receptor
growth stimulatory axis in atypical proliferation of
renal epithelial cells
N de Paulsen, S Lee
Faculty of Medicine,
Department of Cellular and Molecular Medicine and Kidney
Research Center, University of Ottawa, Ottawa, Ontario
Canada |
12:45 |
224 |
Role of the
epidermal growth factor receptor (EGFR) in the
development of malignant peripheral nerve sheath tumors
(MPNST) in patients with neurofibromatosis type 1 (NF1)
and in animal models of NF1
D Clue, H Li, WC Vass, N Ratner
1Laboratory
of Cellular Oncology, National Cancer Institute,
Bethesda, and, 2University of Cincinnati
College of Medicine, Cincinnati, OH 45267 |
13:00 |
225 |
Molecular
analysis of hereditary colorectal cancer: Familial
adenomatous polyposis and Turcots
sindrome
M De Rosa, MI Scarano, L Panariello, G Romano, G Riegler,
GB Rossi, G Pettinato, P Izzo
1Dipto
Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie
Avanzate, and, 2Dipto Scienze Biomorfologiche
e Funzionali, Università di Napoli, Federico, Napoli,
3Chirurgia Generale, Ospedale Moscato,
Avellino, 4Cattedra di Gastroenterologia,
Seconda Università di Napoli, and, Fondazione G. Pascale,
5Endoscopia Digestiva, Ist. Nazionale Tumori,
Fondazione G. Pascale, Napoli |
Poster Presentations
Number |
Title / Authors / Affiliations |
226 |
Impact of the
molecular and clinical screening in Brazilian families
with von Hippel-Lindau disease (VHL)
JCC Rocha, AA Camargo, RLA Silva, O Caballero, AJG
Simpson
1Hospital do
Cancer AC Camargo - Sao Paulo, Sao Paulo, Brazil,
2Ludwig Institute for Cancer Research - Sao
Paulo branch, Sao Paulo, Brazil |
227 |
*Preventive
genetic screening for detection of inherited medullary
thyroid carcinoma (MTC): outcome of the five years
program
M Wiench, J Wloch, Z Wygoda, E Gubala, D Lange, M Oczko,
J Roskosz, A Kukulska, B Jarzab
Dept. of Nuclear
Medicine and Endocrine Oncology, Center of Oncology –
Maria Sklodowska-Curie Memorial Institute, Gliwice
Branch, Poland |
228 |
Differential
expression of hMLH1 and hMSH2 as a potential prognostic
biomarker in bladder cancer
G Xinarianos, JWF Catto, JL Burton, FC Hamdy, M
Meuth
1a) Institute
for Cancer Studies, Academic Unit of Urology, University
of Sheffield, United Kingdom, Sheffield, United Kingdom,
2Academic Unit of Pathology, University of
Sheffield, United Kingdom |
229 |
Establishment of
a new criteria for cancer risk assessment in a Brazilian
cancer center
SN Silva, MJS Floria, MIW Achatz, BM Rossi, RR Brentani,
JCC Rocha
1Department
of Oncogenetics, Hospital do Cancer A.C. Camargo, Sao
Paulo, Brazil, 2Ludwig Institute for Cancer
Research - Sao Paulo branch, Sao Paulo,
Brazil |
230 |
Screening for
predisposing mutations in Polish families with
Li-Fraumeni/Li-Fraumeni- like syndrome or with breast and
ovarian cancer.
L Fiszer-Maliszewska, M Bebenek, B Gorski, B Kazanowska,
G Kurzawski, A Sikorska, D Sorokin, B Wojciechowska
1Institute of
Immunology & Experimental Therapy, Wroclaw, Poland,
2Oncology Center, Wroclaw, Poland,
3Pomeranian Academy of Medicine, Szczecin,
Poland, 4Wroclaw Medical University, Wroclaw,
Poland, 5Institute of Hematology & Blood
Transfusion, Warszawa, Poland |
231 |
Chromosomal
radiosensitivity in lymphocytes of breast cancer patients
with a family history of breast cancer.
A Baeyens, H Thierens, K Claes, L Messiaen, L de Ridder,
A Vral
1Department
of Anatomy, Embryology, Histology and Medical Physics, ,
2Department of Medical Genetics University of
Gent, Belgium |
232 |
Detection of
oncogenic HPV DNA sequences in sporadic
retinoblastoma
MA Palazzi, JA Yunes, IA Cardarelli, G Stangenhaus, SR
Brandalise, SA Ferreira, JSP Sobrinho, LL Villa
1Boldrini's
Children Center, Campinas, Sao Paulo Brazil,
2Department of Virology, Ludwig Institute for
Cancer Research, Sao Paulo, Brazil |
233 |
Facial
resurfacing in xeroderma pigmentosum with chemical
peeling
D Kang, D Ahn
Department of Plastic
and Reconstructive Surgery, Korea University Hospital,
Seoul, Korea Republic |
234 |
Congenital
hypertrophy of the retinal pigment epithelium and APC
gene mutations in familial adenomatous
polyposis
CP Pang, JWY Keung, NLS Tang, DSP Fan, JWY Lau, L Baum,
Lam
1Department
of Ophthalmology & Visual Sciences,
2Department of Chemical Pathology,
3Department of Surgery; the Chinese University
of Hong Kong, Hong Kong, China |
235 |
A case of woman
from the breast/ovarian cancer family, with mutation in
BRCA1 gene and elevated CA-125 serum
level.
K Kaczanowska, JR Kowalczyk, T Byrski, J Lubinski
Department of Pediatric
Hematology and Oncology, Department of Genetics and
Pathology, Medical Acedemy Lublin, Poland, Hereditary
Cancer Center |
236 |
Investigations of
hereditary background of breast and ovarian cancer in
Polish families of Pomeranian - Kujawski
region.
O Haus
Dept Clinical Genetics,
University of Medicine, Bydgoszcz, Poland |
237 |
The effect of
hormonal and demographic factors on clinical presentation
of BRCA1/2 carriers
L Kadouri, B Uzieli, A Hubert, M Gibs, T Hamburger, Z
Gueta, I Lerer, N Weinberg, P Ever-Hadani, D Abeliovich,
T Peretz
1a) Sharett
Institute of Oncology, Human Genetic Laboratory,
2a) Sharett Institute of Oncology, Department
of Biostatistics; Hadassah Medical Center, Jerusalem,
Israel) |
238 |
Genetic analysis
of APC gene in the diagnostics of familial adenomatous
polyposis
S Kapitanovic, T Cacev, K Pavelic
1Division of
Molecular Medicine, Ruder Bokovic Institute, Zagreb,
Croatia, 2PLIVA d.d, Research &
Development, Zagreb, Croatia |
|
Site Contents
- The Journal
- CDP, a peer-refereed
bi-monthly on predictive and preventive oncology
- The Society
- The International Society for Preventive
Oncology
- Meetings
- Network and earn CME credits at our
international symposia.
|